Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular macromolecules and organelles constitute the fundamental structural and functional units of biological systems, including proteins, nucleic acids, lipids, carbohydrates, and specialized compartments such as mitochondria, ribosomes, and the nucleus (National Center for Biotechnology Information [NCBI], 2023). These entities orchestrate all vital cellular processes, from the replication of genetic material and protein synthesis to energy metabolism and signal transduction (StatPearls, 2023). While drug discovery typically focuses on specific molecular targets, many therapeutic classes act by broadly affecting these components; for example, alkylating agents modify DNA macromolecules, and certain antibiotics disrupt the structural integrity of the bacterial cell wall or ribosomal machinery (PubMed, 2022). Dysfunctions within these macromolecules and organelles are central to the etiology of diverse pathologies, including oncogenesis, metabolic disorders, and neurodegeneration (NIH, 2021). Because this term encompasses nearly all biological matter within a cell, it is classified as a high-level biological category rather than a specific, druggable receptor or enzyme. Understanding the interplay between drugs and these cellular components is essential for evaluating systemic toxicity and the broad mechanisms of action of multi-target therapeutics (Nature Reviews Drug Discovery, 2006).
Drugs targeting these components act through various mechanisms such as DNA intercalation, inhibition of protein synthesis, disruption of membrane integrity, or modulation of organelle-specific metabolic pathways (PubMed, 2022; Nature Reviews Drug Discovery, 2006).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular macromolecules and organelles.